NCT00001954View on ClinicalTrials.gov

Etanercept Therapy for Sjogren's Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

November 30, 2003

Conditions
Sjogren's Syndrome
Interventions
DRUG

Etanercept

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00001954 - Etanercept Therapy for Sjogren's Syndrome | Biotech Hunter | Biotech Hunter